Lamas, N.J.; Martel, A.; Nahon-Estève, S.; Goffinet, S.; Macocco, A.; Bertolotto, C.; Lassalle, S.; Hofman, P.
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers 2022, 14, 96.
https://doi.org/10.3390/cancers14010096
AMA Style
Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman P.
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers. 2022; 14(1):96.
https://doi.org/10.3390/cancers14010096
Chicago/Turabian Style
Lamas, Nuno Jorge, Arnaud Martel, Sacha Nahon-Estève, Samantha Goffinet, Adam Macocco, Corine Bertolotto, Sandra Lassalle, and Paul Hofman.
2022. "Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions" Cancers 14, no. 1: 96.
https://doi.org/10.3390/cancers14010096
APA Style
Lamas, N. J., Martel, A., Nahon-Estève, S., Goffinet, S., Macocco, A., Bertolotto, C., Lassalle, S., & Hofman, P.
(2022). Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers, 14(1), 96.
https://doi.org/10.3390/cancers14010096